The relationship of the mean platelet volume and C-reactive protein levels with mortality in ischemic stroke patients

dc.contributor.authorArikanoglu, A.
dc.contributor.authorYucel, Y.
dc.contributor.authorAcar, A.
dc.contributor.authorCevik, M. U.
dc.contributor.authorAkil, E.
dc.contributor.authorVarol, S.
dc.contributor.authorUnan, F.
dc.date.accessioned2024-04-24T17:39:57Z
dc.date.available2024-04-24T17:39:57Z
dc.date.issued2013
dc.departmentDicle Üniversitesien_US
dc.description.abstractBACKGROUND AND OBJECTIVES: The relationship of the mean platelet volume (MPV) and C-reactive protein (CRP) values withmortality in patients with ischemic stroke is not clear. Besides, the correlation between CRP and MPV in patients with ischemic stroke has not been adequately studied yet. In the present study, our aim is to investigate the interrelationship of the CRP and MPV parameters together with their influence on mortality in patients with acute ischemic stroke. PATIENTS AND METHODS: Sixty-three patients with acute ischemic stroke have been enrolled in the study. The stroke patients were divided into 2 groups as those who died within the first 10 days and those who survived. The MPV and CRP in both groups have been compared. Also, the MPV obtained from the ischemic stroke patients were compared with the MPV of the healthy volunteers. RESULTS: A statistically significant difference (p = 0.027) was observed between the MPV of the stroke patients (8.6 +/- 1.95 fL) and the control group (7.93 +/- 0.82 fl). The MPV (9.24 +/- 1.98 fL) and CRP (10.8 +/- 7.0 mg/l) of those ischemic stroke patients who died were statistically significantly higher (p < 0.05) than the MPV (8.09 +/- 1.75 fl) and CRP (3.2 +/- 3.5 mg/l) of the patients who survived. There was also a positive correlation between the MPV and CRP of the ischemic stroke patients (r = 0.31, p = 0.029). CONCLUSIONS: The fact that there is a relationship between the MPV and CRP in ischemic stroke patients and that the CRP and MPV are higher in the ischemic stroke patients who died in comparison to those who survived may be an indication of the roles these markers play in the mortality of stroke patients.en_US
dc.identifier.endpage1777en_US
dc.identifier.issn1128-3602
dc.identifier.issue13en_US
dc.identifier.pmid23852903
dc.identifier.scopus2-s2.0-84884181235
dc.identifier.scopusqualityQ2
dc.identifier.startpage1774en_US
dc.identifier.urihttps://hdl.handle.net/11468/21470
dc.identifier.volume17en_US
dc.identifier.wosWOS:000325203800013
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherVerduci Publisheren_US
dc.relation.ispartofEuropean Review For Medical and Pharmacological Sciences
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectStrokeen_US
dc.subjectMean Platelet Volumeen_US
dc.subjectC-Reactive Proteinen_US
dc.subjectMortalityen_US
dc.titleThe relationship of the mean platelet volume and C-reactive protein levels with mortality in ischemic stroke patientsen_US
dc.titleThe relationship of the mean platelet volume and C-reactive protein levels with mortality in ischemic stroke patients
dc.typeArticleen_US

Dosyalar